BIOLASE (NASDAQ:BIOL) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a research note released on Monday. The brokerage issued a sell rating on the medical technology company’s stock.

BIOLASE Stock Up 6.9 %

Shares of NASDAQ BIOL opened at $0.01 on Monday. The stock’s fifty day simple moving average is $0.01 and its 200 day simple moving average is $0.02. The stock has a market capitalization of $310,685.10, a price-to-earnings ratio of 0.00 and a beta of 0.67. BIOLASE has a 52-week low of $0.02 and a 52-week high of $1.94.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.